Adjuvant Radiotherapy for Cutaneous Melanoma

作者: William M. Mendenhall , Robert J. Amdur , Stephen R. Grobmyer , Thomas J. George , John W. Werning

DOI: 10.1002/CNCR.23306

关键词:

摘要: The purpose of this chapter is to discuss the efficacy adjuvant radiotherapy (RT) in treatment melanoma. risk local-regional recurrence after surgery alone for locally advanced melanoma relatively high. usually related metastatic regional nodes and, occasionally, unfavorable findings at primary site, such as in-transit metastases. likelihood a positive sentinel lymph node biopsy (SLNB) exceeds 20 % melanomas >2 mm thick and or more patients with SLNB will have residual on completion dissection. Patients approximately higher relapse alone, particularly if multiple are involved and/or extracapsular extension present. Postoperative RT results control rates 85–90 high-risk modest complications. impact survival likely minimal.

参考文章(57)
J M Kirkwood, M H Strawderman, M S Ernstoff, T J Smith, E C Borden, R H Blum, Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. Journal of Clinical Oncology. ,vol. 14, pp. 7- 17 ,(1996) , 10.1200/JCO.1996.14.1.7
John M. Kirkwood, Joseph G. Ibrahim, Vernon K. Sondak, Jon Richards, Lawrence E. Flaherty, Marc S. Ernstoff, Thomas J. Smith, Uma Rao, Mary Steele, Ronald H. Blum, High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190 Journal of Clinical Oncology. ,vol. 18, pp. 2444- 2458 ,(2000) , 10.1200/JCO.2000.18.12.2444
Laura L. Kruper, Francis R. Spitz, Brian J. Czerniecki, Douglas L. Fraker, Anne Blackwood-Chirchir, Michael E. Ming, David E. Elder, Rosalie Elenitsas, DuPont Guerry, Phyllis A. Gimotty, Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma Cancer. ,vol. 107, pp. 2436- 2445 ,(2006) , 10.1002/CNCR.22295
Thomas Meyer, Susanne Merkel, Jonas Göhl, Werner Hohenberger, Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Ejso. ,vol. 28, pp. 424- 430 ,(2002) , 10.1053/EJSO.2001.1262
Timothy D. Anderson, Randal S. Weber, Dupont Guerry, David Elder, Lynn Schuchter, Laurie A. Loevner, David I. Rosenthal, Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy. Head and Neck-journal for The Sciences and Specialties of The Head and Neck. ,vol. 24, pp. 1068- 1071 ,(2002) , 10.1002/HED.10141
Irvin Pathak, Ralph Gilbert, John Yoo, Malcolm Hilton, Outcome of neck dissection for node-positive melanoma. Journal of Otolaryngology. ,vol. 31, pp. 147- 149 ,(2002) , 10.2310/7070.2002.10807
Mark D. Bonnen, Matthew T. Ballo, Jeffrey N. Myers, Adam S. Garden, Eduardo M. Diaz, Jeffrey E. Gershenwald, William H. Morrison, Jeffrey E. Lee, Mary Jane Oswald, Merrick I. Ross, K. Kian Ang, Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck Cancer. ,vol. 100, pp. 383- 389 ,(2004) , 10.1002/CNCR.11921
E. Bastiaannet, J.C. Beukema, H.J. Hoekstra, Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treatment Reviews. ,vol. 31, pp. 18- 26 ,(2005) , 10.1016/J.CTRV.2004.09.005
Matthew T. Ballo, Gunar K. Zagars, Jeffrey E. Gershenwald, Jeffrey E. Lee, Paul F. Mansfield, Kevin B. Kim, Luis H. Camacho, Patrick Hwu, Merrick I. Ross, A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Annals of Surgical Oncology. ,vol. 11, pp. 1079- 1084 ,(2004) , 10.1245/ASO.2004.12.039
Martin Dawes, Marko B. Lens, Interferon Alfa Therapy for Malignant Melanoma: A Systematic Review of Randomized Controlled Trials Journal of Clinical Oncology. ,vol. 20, pp. 1818- 1825 ,(2002) , 10.1200/JCO.2002.07.070